Researcher
Wim Robberecht
- Disciplines:Neurosciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
Affiliations
- Laboratory for Neurobiology (VIB-KU Leuven) (Lab)
Member
From1 Jan 2012 → Today - Research Group Experimental Neurology (Division)
Member
From1 Oct 1999 → 31 Dec 2011
Projects
1 - 10 of 29
- Identification, characterization and validation of modifiers of repeat RNA toxicity in C9orf72 amyotrophic lateral sclerosis (ALS)From1 Oct 2018 → 28 Feb 2023Funding: FWO fellowships
- Clin-IC: Medtech solutions for patientsFrom1 May 2018 → TodayFunding: IOF - mandates, IOF - Industrial Research Fund
- Investigating modifiers of C9orf72 induced pathology in Amyotrophic Lateral Sclerosis (ALS) using zebrafish.From1 Jan 2017 → 31 Dec 2019Funding: Foundations, funds and other with scientific goal
- Investigating modifiers of C9orf72 induced pathology in Amyotrophic Lateral Sclerosis (ALS) using zebrafish.From1 Oct 2014 → 30 Sep 2018Funding: FWO fellowships
- The role of EphA4 in neural repair following ischemic strokeFrom1 Apr 2014 → 16 Mar 2020Funding: BOF - Doctoral projects, FWO fellowships
- JP ND-ALS-CarE : A programme for ALS Care in Europe.From1 Feb 2014 → 31 Jan 2019Funding: FWO research project (including WEAVE projects)
- Identifying COL4A1 and COL4A2 mutations in sporadic cerebral white matter diseaseFrom1 Jan 2014 → 31 Dec 2014Funding: FWO research grant KAN
- The ephrin axon repellent system in amyotrophic lateral sclerosis (ALS).From1 Jan 2014 → 31 Dec 2016Funding: Foundations, funds and other with scientific goal
- The mechanism of mutant C9orf72 in the pathogenesis of Amyotrophic Lateral Sclerosis/Frontotemporal Lobe Degeneration.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- The ephrin axonal repellent system in Amyotrophic Lateral Sclerosis.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
Publications
41 - 50 of 198
- HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease(2018)
Authors: Veronick Benoy, Lawrence Van Helleputte, Robert Ciarán Prior, Pieter Vanden Berghe, Philip Van Damme, Wim Robberecht, Ludo Van Den Bosch
Pages: 673 - 687 - Reconsidering the causality of TIA1 mutations in ALS(2018)
Authors: Matthieu Moisse, Wim Robberecht, Philip Van Damme
Pages: 1 - 3 - Amyotrophic lateral sclerosis(2017)
Authors: Wim Robberecht
Pages: 17085 - HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients(2017)
Authors: Wenting Guo, Laura Fumagalli, Tijs Vandoorne, Ruben Boon, Samie PATEL, Tine Tricot, Veronick Benoy, Jolien Steyaert, Werend Boesmans, Pieter Vanden Berghe, et al.
Pages: 861 - Amyotrophic lateral sclerosis(2017)
Authors: Orla Hardiman, Ammar Al-Chalabi, Adriano Chio, Emma M Corr, Giancarlo Logroscino, Wim Robberecht, Pamela J Shaw, Zachary Simmons, Leonard H van den Berg
Pages: 17085 - Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo(2017)
Authors: Sander Beel, Matthieu Moisse, Louis De Muynck, Wim Robberecht, Ludo Van Den Bosch, Philip Van Damme
Pages: 2850 - 2863 - Identification and characterization of Nanobodies targeting the EphA4 receptor(2017)
Authors: Lucia Chavez Gutierrez, Maarten Dewilde, Bart De Strooper, Ludo Van Den Bosch, Philip Van Damme, Robin Lemmens, Wim Robberecht
Pages: 11452 - 11465 - Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial(2017)
Authors: Wim Robberecht
Pages: 149 - 152 - Mechanisms in C9orf72 linked ALS and FTLD(2017)
Authors: Steven Boeynaems, Wim Robberecht, Ludo Van Den Bosch, Philip Van Damme
- Modelling amyotrophic lateral sclerosis: progress and possibilities(2017)
Authors: Philip Van Damme, Wim Robberecht, Ludo Van Den Bosch
Pages: 537 - 549
Patents
1 - 6 of 6
- Single domain antibodies against sod1 and their use in medicine (Inventor)
- Hdac inhibitors to treat charcot-marie-tooth disease (Inventor)
- SINGLE DOMAIN ANTIBODIES AGAINST SOD1 AND THEIR USE IN MEDICINE (Inventor)
- HDAC inhibitors to treat charcot-marie-tooth disease (Inventor)
- SINGLE DOMAIN ANTIBODIES AGAINST SOD1 AND THEIR USE IN MEDICINE (Inventor)
- USE OF EPHRIN TYPE-A RECEPTOR 4 SIGNALING INHIBITOR FOR TREATMENT OF MOTOR NEURON DISEASE CHOSEN FROM AMYOTROPHIC LATERAL SCLEROSIS AND SPINAL MUSCULAR ATROPHY (Inventor)